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Abstract
Renal cell carcinoma is a potentially lethal cancer with aggressive behavior and a propensity for metastatic spread.
Due to the fact that the patterns of metastases from renal cell carcinomas are not clearly defined, there have been
several reports of cases of renal cell carcinoma associated with rare metastatic sites and atypical presenting
symptoms. The present review focuses on these atypical rare clinical presentations of renal cell carcinomas both at
the time of diagnosis of the primary tumor but also in the years after radical nephrectomy.
Introduction
Renal cell carcinoma (RCC) is a lethal tumor that
accounts for approximately 3% of all adult malignancies
and is associated with approximately 13,000 deaths
annually [1]. The introduction and widespread use of
sophisticated imaging modalities has resulted in a signif-
icant increase in the incidental detection of kidney
tumors. Nowadays more than 70% of all renal cancer
cases are “screen detected” as incidental findings on
imaging studies obtained for unrelated reasons [2].
Therefore the classical teaching that renal cancer pre-
sents with signs and symptoms such as hematuria, flank
pain and palpable mass is more of the exception rather
than the rule. This trend has also resulted in a signifi-
cant shift in the staging of renal cancer since lesser
cases initially present with advanced metastatic disease
and more cases of renal tumors are confined to the kid-
ney at the time of diagnosis.
Still, renal cancers have a strong tendency to metasta-
size following occasionally unpredictable patterns of
spread. There have been several reports of late metas-
tases from RCC even decades after potentially curative
surgical excision of the primary tumor. There is evi-
dence that distant metastatic disease will eventually
develop in about one out of three patients with RCC
and in these cases the disease is considered incurable.
Even despite recent therapeutic advances in the manage-
ment of metastatic renal cancer such as immunotherapy
and mTOR kinase inhibitors, long-term survival in
patients with metastatic RCC is limited to months [3-5].
With regard to the histologic subtypes of RCC and
their relationship to prognosis, the most common sub-
type, which is clear cell renal cancer, accounts for 70-
80% of all RCCs. Chromophobe cell carcinoma accounts
for only 3-5% of all RCCs and carries a better prognosis
than clear cell RCC with a five-year survival rate
between 92-94% [6,7]. The pathologic stage of RCC at
the time of presentation has been demonstrated to cor-
relate most closely with survival [8].
Metastatic pathway in RCC
The development of metastatic disease is a sequential
process where cancer cells depart from the primary
tumor via the blood supply or lymphatic chain and
deposit at proximal or distant sites. This metastatic
pathway is not always predictable and certainly not for
renal cancer, which is notorious for its complex lympha-
tic drainage. However there is a predilection for certain
sites, meaning that these sites are usually the first occu-
pied by cancer cells [9]. Moreover, there has been evi-
dence in support of an early dissemination model,
where metastasis occurs early in the lifecycle of cancer
cells.
In an experimental study, engineered untransformed
mouse mammary cells were found to express inducible
oncogenes transgenes that were able to bypass the pri-
mary site and show up at secondary metastatic sites
[10]. In another animal study, Kaplan et al.a l s os h o w e d
that cancer cells in mice models might have instructed
bone marrow cells to migrate to pre-selected organs in
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preceded the appearance of cancer cells by four to six
days and micrometastatic colonies formed five days later
[11]. These studies might explain the unpredictable
metastatic pattern of renal tumors and account for the
late appearance of metastatic disease in organs and sites
that are considered outside of the “usual” metastatic
pathway of RCC.
Rare metastatic sites of renal cell cancer
A Medline/PubMed search for articles in English
(mostly case series and case reports) on rare metastatic
sites of renal carcinomas was performed. In our search
we considered as rare all sites that were anatomically
distal to the kidney and outside the considered usual
chain of metastatic spread of renal tumors. For that rea-
son we excluded all sites of common metastases from
renal tumors, including the lungs, adrenals, intestines
and brain and most intra-abdominal organs, and only
included rare metastatic sites outside the abdomen.
Head and neck
RCC is the third most frequent neoplasm to metastasize
to the head and neck region preceded only by breast and
lung cancer. Despite being reported infrequently, head
and neck region metastases may be linked to RCC in up
to 15% of cases [12]. The nose and paranasal sinuses are
most commonly affected, followed by the oral cavity.
Orbit
Ocular metastases from RCCs are extremely rare. Dur-
ing the last five years only 19 cases have been reported.
Ocular metastases are more likely to involve the iris,
ciliary body and choroids, although eyelid, lacrimal sac
and orbital metastases have also been described [13-16].
Among those 19 cases, 13 involved men and only three
involved women. In three cases there was no mention of
the gender. The mean age at initial diagnosis was 50
years. In seven cases the eye or orbital metastasis was
the first manifestation of a previously unknown RCC,
while in 10 cases there was a history of nephrectomy for
RCC (one month to 17 years before the diagnosis of the
ocular metastatic lesion). In two cases there was no
mention of the previous medical history. The patients
presented with several symptoms depending on the
localization of the tumor, such as proptosis, diplopia,
eye vision difficulties, cataract, upper lid tumor, and epi-
phora. The final diagnosis occurred after excision biopsy
which revealed metastatic RCC. In Table 1 all cases
with metastases to the orbit are presented in detail.
Parotid gland
Major salivary gland metastases from distant primary
tumors are very uncommon. Parotid metastatic lesions
may originate from hepatocellular carcinoma, squamous
cell carcinoma, melanoma, retinoblastoma, carcinoma of
the breast, urachus, prostate, stomach, lungs or kidneys.
An extensive literature search revealed a total of 26
cases of RCC metastatic to the parotid gland. In 14 of
these patients, parotid metastasis was the initial sign of
the kidney tumor. In the other 12 cases, parotid metas-
tasis occurred after nephrectomy for RCC, at a time
interval ranging from months to years [17-22].
To the best of our knowledge, the longest interval
from nephrectomy to solitary parotid metastasis was 10
years. The most common presenting symptom was the
presence of a palpable parotid mass, while in one case
facial paralysis was the presenting symptom. In all cases
fine-needle aspiration (FNA) biopsy was diagnostic.
Some cases are presented in detail in Table 2[17-26].
With regard to solitary submaxillary gland metastasis
from RCC, we were able to retrieve three cases. These
involved an 83-year-old man where metastatic tumor
presented 10 years after primary treatment; a 52- year-
old woman with a growing mass at the base of her ton-
gue (minor salivary gland) and no known history of
renal cancer and a 61-year-old patient who presented
seven years after primary treatment, with metastasis to
both the submandibular glands and the thyroid [26,27].
Nasal and paranasal cavities
The nose is another very uncommon site for metastatic
RCC. Approximately 50 cases of nasal recurrences of
RCC have been reported in the literature. The maxillary
sinuses are the paranasal sinuses most commonly
afflicted by metastatic tumors to the sinonasal region,
followed in frequency by the ethmoid, frontal, and sphe-
noid, while there is only one reported case of an isolated
metastasis to the nasal septum.
Tumor involvement of the paranasal sinuses and nasal
fossae appears to occur via the hematogenous route
through the Batson’s paravertebral venous plexus. This
is an anastomotic network of avalvular veins surround-
ing the bone marrow and vertebras, connected with pel-
vic, intercostal, azygos and cava veins, therefore allowing
tumor seeding in both a caudal direction toward the
pelvis and a cranial direction to the calotte. Increased
intra-abdominal or intrathoracic pressure causes an
increased flow to the paravertebral plexus, from which
venous sinuses in the calotte, and retrogradely the ptery-
goid plexus, are reached before arriving at the paranasal
sinuses. This theory explains how tumor cells may
escape the pulmonary capillary filter and how renal, pul-
monary, genitourinary, or breast tumors can metastasize
into the paranasal sinuses [28].
The most frequent patients’ complaints were nasal
obstruction, swelling and pain, although epistaxis is the
most alarming symptom because of the high vascular
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of RCC resulting in bleeding is probably caused by the
fact that the von Hippel-Lindau gene mutation causes
upregulation of hypoxia-induced factor 1a, which in turn
l e a d st oa n g i o g e n e s i st h r o u gh vascular endothelial
growth factor upregulation. In cases of uncontrollable
bleeding, immediate surgical removal is mandatory [29].
In 15 of these cases there was no known history of
renal mass, while the rest of the patients had previously
undergone nephrectomy at a time interval ranging from
eight to 18 years prior to the diagnosis of the metastatic
lesion to the nasal or paranasal cavities. In the majority
of the cases there were also synchronous metastases to
other parts of the body like small intestine, lungs and
thyroid glands. The definitive diagnosis (Table 3) was
based on pathology of the lesion, supplemented by ima-
ging studies (computed tomography and magnetic reso-
nance imaging (MRI)) [30-33].
Tongue and tonsils
The tongue is a frequent target for RCC metastasis
although isolated spread to the floor of the mouth is
rare. Lesions in the tongue or floor of the mouth can
cause severe pain, bleeding, difficulty eating and even
complete oral obstruction. Unfortunately, oral cavity
metastasis from RCC is usually a manifestation of wide-
spread disease [34]. The literature review revealed 28
cases of RCC metastatic to the tongue. Out of these,
only five cases presented initially with tongue metastases
before the primary diagnosis of RCC [35,36].
Table 1 Cases of RCC metastases to the orbit
Patient sex
age at
diagnosis
Location Treatment of
primary
tumor
Interval between diagnosis of
primary tumor and metastasis
(months)
Diagnosis of metastasis
before primary
treatment
Presenting
symptoms
Metastases
to other sites
m/54 Uvea Nephrectomy 36 no Eye vision
problem
-
NA Bilateral lacrimal
gland
NA NA NA NA -
m/43 Choroidal and
conjunctival
Nephrectomy 12 no Left orbital
pain
-
NA Choroidal, ocular,
extraocular,
vitreous
Nephrectomy 96 no Cataract -
m/52 Choroidal Nephrectomy 24 no Eye vision
problem
Lung
m/63 Eyelid Nephrectomy/
chemotherapy
NA no Upper lid
tumor
Lung
m/58 Inferior rectus
muscle
- Metastasis first yes Proptosis
and
diplopia
-
f/NA Lacrimal sac Nephrectomy NA NA Epiphora -
m/73 Orbit Nephrectomy 204 no Epistaxis Nasal cavity,
ethmoidal
sinus
m/67 Iris Nephrectomy NA no NA -
m/58 Orbit - Metastasis first yes NA -
f/23 Orbit Nephrectomy one no NA -
f/60 Orbit - Metastasis first yes Proptosis -
m/69 Orbit - Metastasis first yes Proptosis -
m/66 Eyelid Nephrectomy 15 no NA Lung, skin,
brain
m/47 Eyelid Nephrectomy 33 no NA Abdomen,
skin, lung
m/59 Retroocular - Metastasis first yes Proptosis
and
diplopia
-
m/72 Conjuctival - Metastasis first yes Ulcerated
lesion
-
m/70 Orbit - Metastasis first yes Cataract -
f: female; m: male; NA: not available
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patients with lingual metastasis from RCC is poor.
Treatment of tongue metastasis is usually palliative and
aims to provide patient comfort by means of pain relief
while preventing bleeding, infection and breathing diffi-
culties. Surgical excision is recommended as palliative
treatment with emphasis on preservation of tongue
structure and function [34-42].
Table 2 Cases of RCC metastases to the salivary glands
Patient sex and
age at diagnosis
Location Treatment of
primary tumor
Interval between diagnosis of primary
tumor and metastasis (months)
Diagnosis of metastasis
before primary treatment
Presenting
symptoms
NA parotid gland NA NA NA facial nerve palsy
f/58 parotid gland - Metastasis first yes painless mass
f/76 parotid gland Nephrectomy 108 no painless mass
f/62 parotid gland Nephrectomy 60 no painless mass
NA parotid gland NA NA NA painless mass
NA parotid gland NA NA NA painless mass
NA parotid gland Nephrectomy NA no painless mass
NA parotid gland Nephrectomy 120 no painless mass
NA parotid gland Nephrectomy 24 NA painless mass
m/66 parotid gland Nephrectomy 18 NA painless mass
m/69 parotid gland Nephrectomy 24 no painless mass
f/59 parotid gland Nephrectomy 120 no painless mass
f/61 parotid gland - Metastasis first yes painless mass
m/83 submaxillary
gland
Nephrectomy 120 no NA
f/52 minor salivary
gland
- Metastasis first yes NA
f/61 submandibular
glands
Nephrectomy 84 no Painless
submandibular
swelling
f: female; m: male; NA: not available
Table 3 RCC metastases to the nasal and paranasal regions
Sex/age at
diagnosis
Location Treatment of
primary tumor
Interval between diagnosis of
primary tumor and metastasis
Diagnosis of metastasis
before primary treatment
Presenting
symptoms
Metastases to
other sites
f/65 Nasal Nephrectomy 17 years no epistaxis Thyroid, small
intestine
m/58 Maxillary
Sinus
Nephrectomy 11 years no lasting nasal
obstruction
Lung
f/69 Nasal Nephrectomy NA no NA Lung
f/60 Maxillary
Sinus
Nephrectomy 10 years no Hyposmia,
pain
-
f/87 Maxillary
Sinus
Nephrectomy eight years no epistaxis, nasal
obstruction
-
m/71 Nasal Nephrectomy NA no epistaxis, nasal
obstruction
Lung
N.A Nose - Metastasis first yes NA -
m/73 Ethmoid
sinus
- Metastasis first yes epistaxis -
N.A Ethmoid
sinus
Nephrectomy 17 years NA epistaxis, nasal
obstruction
-
f/45 Nasal
Septum
-N A N A N A -
m/70 Nasosinusal - Metastasis first yes epistaxis -
m/60 Maxillary
Sinus
Nephrectomy six months NA NA -
f: female; m: male; NA: not available
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metastases from RCC have been reported during the
last five years. Both patients were men, 61- and 76-
years-old respectively, with known history of RCC and
previously diagnosed bone and lung metastases [41,42].
Thyroid gland
Although secondary involvement of the thyroid gland by
RCC is uncommon, more than 150 cases of clinically
recognized metastatic RCC to the thyroid have been
reported in the English literature. Metastatic disease
f r o mt h ek i d n e yt ot h et h y r o i dg l a n dc a no c c u rm o r e
than 20 years after nephrectomy, with an average time
interval of approximately seven and a half years. Among
them we found only five cases where metastasis to the
thyroid gland was the first manifestation of RCC
[43-45]. Some cases are depicted in Table 4[43-48].
There are hypotheses explaining the relatively high
incidence of metastases from the kidney to the thyroid
gland. Although a popular theory claims that the pro-
clivity of metastasis to the thyroid gland is related to its
rich blood supply, some researchers have suggested that
the abnormal thyroid gland isv u l n e r a b l et om e t a s t a t i c
growth due to a decrease in oxygen and iodine content
alteration [49].
Metastatic disease to the thyroid can manifest as
breathing difficulties due to enlargement-swelling of the
thyroid causing airway obstruction. Other symptoms
include trouble or pain in swallowing, cough due to the
vasogastric effect or a variety of symptoms of hypothyr-
oidism [50]. Diagnosis is confirmed by thyroid scintigra-
phy, thyroid ultrasonography, and cytology of the
material obtained through FNA [51].
Heart
Isolated metastasis of RCC to the left ventricle of the
heart is considered a rare incident. Historically, up to
10% of patients with RCC have tumor thrombus
involving the renal vein and inferior vena cava and in
up to 1% tumor thrombus extends into the right atrium.
Metastasis to the left ventricle as to any other organ is
possible via the hematogenous route. There have been
rare reports of solitary late metastasis to the heart with
the right ventricle being the preferred chamber involved.
Metastasis to the heart may have two distinct origins
and clinical features. The first is hematogenous, via the
inferior vena cava, even in the absence of renal vein
involvement; it is generally circumscribed and has a
good prognosis after surgery. The second is through the
intrathoracic lymphatic system, in the presence of disse-
minated disease, especially pulmonary metastasis. This
type has a very poor prognosis [52].
There have been 10 reports within the last five years
of cardiac metastases from RCC. In one case, a malig-
nant pericardial effusion was the sole evidence of meta-
static disease and was treated by radiation therapy [53].
In three cases [53-55] right atrial metastasis occurred,
one of which displayed the absence of a vena cava
tumor extension [54]. In three cases left ventricular
metastasis occurred 18 to 23 years after nephrectomy
[56-58]. In two cases there was right ventricular metas-
tasis from RCC, which was diagnosed incidentally after
an episode of syncope in the first case [59] and during
the evaluation of hematuria in the second one [60].
Finally one case involved metastasis to the interventricu-
lar septum which caused cardiac paradox [61]. In Table
5 those cases are presented in detail.
Skin
Skin metastases of RCC are not easily identified because
of the low suspicion index for these skin lesions, which
usually mimic common dermatological disorders. More-
over in the majority of cases the pathogenesis of the
skin lesion is not related to the primary tumor due to
the long time interval since nephrectomy. Skin metas-
tases have been reported to occur in around 3% of renal
Table 4 Cases of RCC metastases only to the thyroid gland
Sex/age at
diagnosis
Treatment of primary
tumor
Interval Between Diagnosis of primary tumor
and metastases
Diagnosis of Metastasis
before PT
Symptom
m/54 - Metastasis first yes Dysphagia
m/73 Nephrectomy eight years NA Painful mass,
dyspnoea
f/61 Nephrectomy seven years no N.A
m/72 Nephrectomy 17 years no swelling
f/66 Nephrectomy 16 years no N.A
m/61 Nephrectomy eight years no swelling, cough
m/68 Nephrectomy two years no asymptomatic
4 m/60-83, 6f/56-
83
Nephrectomy in six
cases
yes in four cases
f: female; m: male; NA: not available
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of calvarial metastases as secondary lesions from RCC
have been reported in the literature, but only five cases
have been described concerning calvarial mass as the
first clinical presentation of metastatic RCC [62-64].
Skin metastases mainly occur in the head, neck and
trunk, in that order. Skin metastases from RCC occur in
most patients at a late stage of the disease, usually years
after nephrectomy for an organ-confined tumor. How-
ever in some cases they may occur even before the renal
tumor is diagnosed [65]. Skin metastases are usually
considered late manifestations of the disease, bearing a
poor prognosis that is associated to synchronous visceral
metastases in up to 90% of cases, resulting in tumor-
specific survival of usually shorter than six months
[66-73].
Ovaries-Uterus-Testis
Metastasis to the ovaries is thought to occur by retro-
grade venous embolization through the renal vein to the
ovarian vessels. In an autopsy study, ovarian metastasis
was found in 0.5% of cases of renal cancer. Metastasis
through this pathway exploits the unique anatomy of
the left renal and ovarian veins. It mandates incompe-
tent gonadal veins to allow for retrograde venous blood
flow. As a matter of fact, two thirds of reported cases
arose from a left-sided lesion. Thus, it appears that the
hallmark for the renal-ovarian axis is its unique venous
anatomy. Only 21 cases of metastasis to the ovary from
RCC have been reported in the literature (eight cases in
the last five years). Out of these, 17 cases were
metastasis of RCC of clear cell type. Six of these cases
were diagnosed as primary ovarian clear cell cancer,
while renal primary was diagnosed only after extensive
investigations [74-81].
Regarding the vagina and uterus, to our knowledge,
there is one report in the literature of metastatic onco-
cytic papillary RCC to the endometrium in an 89-year-
old woman presented with vaginal bleeding, one of vagi-
nal metastasis from RCC and another one of cervical
carcinoma in a 45-year-old woman [80,81].
With regard to metastatic testicular involvement, the
incidence of secondary testicular tumors ranges from
0.3% to 3.6% with the most frequent primary site being
the prostate [82]. Intrascrotal metastasis arising from
RCC has also been reported [83]. The pathologic diag-
nosis of RCC metastatic to the testis almost always
reveals a clear cell tumor pathology [84]. To our knowl-
edge only six cases of testicular metastases from RCC
have been reported within the last five years, in one of
the six, there was a contralateral chromophobe RCC
metastatic to the testis, six years after nephrectomy
[85,86].
Muscle and joints
RCC metastatic to muscles is a very rare incident
indeed. According to Satake et al., up until 2009 only 32
cases of skeletal muscle metastasis from RCC had been
reported; our search added another three. The fact is
that there are very few cases with muscle metastasis
from RCC with each metastatic location comprising a
unique case report [87,88].
Table 5 Cases with RCC metastasis to the heart, N
Sex/age at
diagnosis
Location Treatment of
primary tumor
Interval between diagnosis of
primary tumor and metastasis
Diagnosis of metastasis
before primary treatment
Presenting
symptoms
IVC
involvement
f/67 Interverticular
septum
Nephrectomy three months no Dyspnea N.A
m/50 Right atrium Nephrectomy six years no Budd-Chiari
Syndrome
Yes
m/59 Right
ventricle
- Metastasis first yes Syncope No
m/59 Pericardial,
myocardial
Nephrectomy NA no Cardiac arrest No
m/69 Left ventricle Nephrectomy 23 years no NA NA
m/65 Left ventricle Nephrectomy 20 years no NA NA
m/50 Right atrium Nephrectomy one year No Raynaud-like
phenomena,
fatigue
No
f/59 Right atrium - zero synchronous NA Yes
m/69 Left ventricle Nephrectomy 18 years No Shortness of
breath
No
m/55 Right
ventricle
- zero synchronous Hematuria No
f: female; m: male; NA: not available
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asymptomatic RCC have been described. The patients
were initially diagnosed with septic arthritis. However
the finding of hot spots on isotope bone scans and
biopsy samples showing secondary neoplasms confirmed
the lesions to represent metastatic sites of RCCs. MRI
has been proven helpful in delineating the features and
extent of the muscle invasion by the tumor [88,89].
Conclusions
RCC represents a potentially lethal cancer that is asso-
ciated with aggressive behavior and has a propensity for
metastatic spread. The patterns of metastases from
RCCs are not yet defined with accuracy and, as a result,
RCC has been associated with rare metastatic sites and
occasionally atypical presenting symptoms from dissemi-
nated disease and distant metastatic sites.
The present review has focused on these rare inci-
dences of metastatic spread of RCC to uncommon sites
and organs both at the time of diagnosis of the primary
tumor but also years after radical nephrectomy. This
review is mainly based on published case reports rele-
vant to the metastatic potential of RCC. This fact
further highlights the significance of case reporting,
especially in oncology where clinical trials or even large
case series are not always available, as Dib et al.h a v e
very elegantly pointed out [90]. The contribution of case
reporting should not be underestimated since many of
our classical clinical teachings have originated from the
observation of isolated “case reports”.
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